Parallax Volatility Advisers, L.P. Eli Lilly & CO Call Options Transaction History

Parallax Volatility Advisers, L.P.

$45.1 Billion
Q2 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $41.5 Million - $52.1 Million	-57,300 Reduced 74.9%	19,200 $17.4 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $41 Million - $54.8 Million	-69,200 Reduced 47.49%	76,500 $59.5 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $32.1 Million - $37.8 Million	61,100 Added 72.22%	145,700 $84.9 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $19.3 Million - $26.5 Million	-44,300 Reduced 34.37%	84,600 $45.4 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $2.42 Million - $3.24 Million	-6,900 Reduced 5.08%	128,900 $60.5 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $4.41 Million - $5.18 Million	-14,200 Reduced 9.47%	135,800 $46.6 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $17.6 Million - $20.5 Million	54,600 Added 57.23%	150,000 $54.9 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $25.8 Million - $29.4 Million	87,000 Added 1035.71%	95,400 $30.8 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $6.05 Million - $7.1 Million	-21,700 Reduced 72.09%	8,400 $2.72 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $32.2 Million - $40 Million	-137,300 Reduced 82.02%	30,100 $8.62 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $17.8 Million - $22.1 Million	-79,300 Reduced 32.14%	167,400 $46.2 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $74 Million - $91 Million	-333,800 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $54.7 Million - $67.3 Million	246,700 New	246,700 $57 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $9.97 Million - $12.9 Million	55,200 Added 19.81%	333,800 $76.6 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $28 Million - $36.3 Million	170,700 Added 158.2%	278,600 $52 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $14.1 Million - $18.6 Million	107,900 New	107,900 $18.2 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $20.5 Million - $27.1 Million	-157,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $11.9 Million - $13.8 Million	-81,400 Reduced 34.14%	157,000 $23.2 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $4.11 Million - $4.94 Million	30,100 Added 14.45%	238,400 $39.1 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $1.35 Million - $1.67 Million	11,300 Added 5.74%	208,300 $28.9 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $4.94 Million - $6.12 Million	46,200 Added 30.64%	197,000 $25.9 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $149,506 - $162,624	-1,400 Reduced 0.92%	150,800 $16.9 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $24.1 Million - $28.1 Million	-217,400 Reduced 58.82%	152,200 $16.9 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $23 Million - $27.1 Million	206,800 Added 127.03%	369,600 $48 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $12.2 Million - $13.7 Million	115,600 Added 244.92%	162,800 $18.8 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $4.05 Million - $5.07 Million	47,200 New	47,200 $5.06 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$88.1 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.9M
Shares

$67.2 Billion
1.31% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$59.9 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$46.7 Billion
31.1% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$30.8 Billion
1.36% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account